Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Palermo

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Clinical Genitourinary Cancer|December 14, 2020
Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non-Muscle-Invasive Bladder CancerLuca Di Gianfrancesco, Mauro Ragonese, Giuseppe Palermo, et al.
Urologia|January 16, 2015
[Surgery for male urinary incontinence: where are we now and what is in the pipeline?]Riccardo Bientinesi, Salvatore Marco Recupero, Giuseppe Palermo, et al.
BMC Cancer|December 8, 2018
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "BCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomesMarco Racioppi, Luca Di Gianfrancesco, Mauro Ragonese, et al.
Annals of Translational Medicine|May 9, 2017
Preclinical atherosclerosis in patients with inflammatory bowel diseases: a case-control studyVincenzo Bruzzese, Giuseppe Palermo, Lorenzo Ridola, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|February 21, 2019
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?Marco Racioppi, Luca Di Gianfrancesco, Mauro Ragonese, et al.
Current Urology|October 7, 2022
How to reduce bacillus Calmette-Guérin discontinuation in patients with severe functional impairmentLuca Di Gianfrancesco, Mauro Ragonese, Massimiliano Foti, et al.
Urologia|April 6, 2013
[Therapeutic strategies in penile cancer: state of the art]Gaetano Gulino, Giuseppe Palermo, Michele Antonucci, et al.
Frontiers in Neurology|June 7, 2021
Ranking the Predictive Power of Clinical and Biological Features Associated With Disease Progression in Huntington's DiseaseNaghmeh Ghazaleh, Richard Houghton, Giuseppe Palermo, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|December 6, 2012
Urological complications following inguinal hernioplastyGaetano Gulino, Michele Antonucci, Giuseppe Palermo, et al.
Current Urology|October 7, 2022
The indispensable role of urinalysis for patients undergoing treatment for nonmuscle invasive bladder cancerLuca Di Gianfrancesco, Mauro Ragonese, Giuseppe Palermo, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Clinical Genitourinary Cancer|December 14, 2020
Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non-Muscle-Invasive Bladder CancerLuca Di Gianfrancesco, Mauro Ragonese, Giuseppe Palermo, et al.
Urologia|January 16, 2015
[Surgery for male urinary incontinence: where are we now and what is in the pipeline?]Riccardo Bientinesi, Salvatore Marco Recupero, Giuseppe Palermo, et al.
BMC Cancer|December 8, 2018
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "BCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomesMarco Racioppi, Luca Di Gianfrancesco, Mauro Ragonese, et al.
Annals of Translational Medicine|May 9, 2017
Preclinical atherosclerosis in patients with inflammatory bowel diseases: a case-control studyVincenzo Bruzzese, Giuseppe Palermo, Lorenzo Ridola, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|February 21, 2019
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?Marco Racioppi, Luca Di Gianfrancesco, Mauro Ragonese, et al.
Current Urology|October 7, 2022
How to reduce bacillus Calmette-Guérin discontinuation in patients with severe functional impairmentLuca Di Gianfrancesco, Mauro Ragonese, Massimiliano Foti, et al.
Urologia|April 6, 2013
[Therapeutic strategies in penile cancer: state of the art]Gaetano Gulino, Giuseppe Palermo, Michele Antonucci, et al.
Frontiers in Neurology|June 7, 2021
Ranking the Predictive Power of Clinical and Biological Features Associated With Disease Progression in Huntington's DiseaseNaghmeh Ghazaleh, Richard Houghton, Giuseppe Palermo, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|December 6, 2012
Urological complications following inguinal hernioplastyGaetano Gulino, Michele Antonucci, Giuseppe Palermo, et al.
Current Urology|October 7, 2022
The indispensable role of urinalysis for patients undergoing treatment for nonmuscle invasive bladder cancerLuca Di Gianfrancesco, Mauro Ragonese, Giuseppe Palermo, et al.
Pageof 9